Updated terms for new Nafta put hold on potential price increases for some drugs

TORONTO — A change affecting pharmaceuticals in the updated North American free trade agreement will mean cost savings for Canadians, but big drug companies say it could affect investment. Final terms in the trade deal remove a provision that would have increased protections to 10 years around a category of drugs called biologics. It means Canada, which had come under some criticism […]